A Randomized Phase 2 Study of Ruxolitinib Efficacy and S

Project: Research project

Project Details

Description

A Randomized Phase 2 Study of Ruxolitinib Efficacy and Safety in Combination with CApecitabine for subjects with recurrent or treatment refractory metastatic Pancreatic Cancer (the RECAP trial)
StatusFinished
Effective start/end date8/1/118/30/16

Funding

  • Incyte Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.